Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$749,900.00
Oct 1, 2011
Molecular Regulation of E2F-1 Dependent Gene Transcription and Cell Death Signaling Pathways in Ventricular Myocytes
$76,244.00
Oct 1, 2011
Reassessment of anti-platelet therapy using individualized strategies - Association of genetic variants to adverse outcomes in clopidogrel treated patients after percutaneous coronary intervention: the RAPID AGAP study
$812,446.00
Oct 1, 2011
Roles of carcinoma associated fibroblasts and tumor stromal genes in lung cancer
$747,275.00
Oct 1, 2011
Glucose regulation of insulin secretion and metabolic enzymes' gene expression
$1,473,232.00
Oct 1, 2011
Mutational and Functional Analysis of Genes Identified by GWAS Studies of Alzheimer's Disease
$521,739.00
Oct 1, 2011
Gene Delivery of Glucagon-like Peptide-1 (GLP-1) for the Treatment of Type 2 Diabetes
$147,500.00
Oct 1, 2011
Evaluation of MRI-controlled interstitial ultrasound therapy for the treatment of cerebral neoplasms
$483,410.00
Oct 1, 2011
A novel anti-angiogenic therapy for endometriosis
$1,954,258.00
Oct 1, 2011
Simvastatin Therapy for Moderate and Severe COPD (STATCOPE)
$708,963.00
Oct 1, 2011
Strategies for therapy of respiratory muscle failure in muscular dystrophy.